327 related articles for article (PubMed ID: 11445737)
1. Activated protein C versus protein C in severe sepsis.
Yan SB; Dhainaut JF
Crit Care Med; 2001 Jul; 29(7 Suppl):S69-74. PubMed ID: 11445737
[TBL] [Abstract][Full Text] [Related]
2. Endogenous protein C activation in patients with severe sepsis.
Liaw PC
Crit Care Med; 2004 May; 32(5 Suppl):S214-8. PubMed ID: 15118520
[TBL] [Abstract][Full Text] [Related]
3. New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).
Macias WL; Yan SB; Williams MD; Um SL; Sandusky GE; Ballard DW; Planquois JM
Crit Care; 2005; 9 Suppl 4(Suppl 4):S38-45. PubMed ID: 16168074
[TBL] [Abstract][Full Text] [Related]
4. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.
Dhainaut JF; Yan SB; Cariou A; Mira JP
Crit Care Med; 2002 May; 30(5 Suppl):S318-24. PubMed ID: 12004254
[TBL] [Abstract][Full Text] [Related]
5. Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.
Faust SN; Heyderman RS; Levin M
Crit Care Med; 2001 Jul; 29(7 Suppl):S62-7; discussion S67-8. PubMed ID: 11445736
[TBL] [Abstract][Full Text] [Related]
6. Protein C in critical illness.
Mann HJ; Short MA; Schlichting DE
Am J Health Syst Pharm; 2009 Jun; 66(12):1089-96. PubMed ID: 19498123
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis.
Grinnell BW; Joyce D
Crit Care Med; 2001 Jul; 29(7 Suppl):S53-60; discussion S60-1. PubMed ID: 11445735
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human activated protein C in severe sepsis.
Mann HJ
Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S19-23. PubMed ID: 11885409
[TBL] [Abstract][Full Text] [Related]
9. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.
Esmon CT
Crit Care Med; 2001 Jul; 29(7 Suppl):S48-51; discussion 51-2. PubMed ID: 11445734
[TBL] [Abstract][Full Text] [Related]
10. New and emerging therapies for sepsis.
Healy DP
Ann Pharmacother; 2002 Apr; 36(4):648-54. PubMed ID: 11918516
[TBL] [Abstract][Full Text] [Related]
11. Protein C/activated protein C pathway: overview of clinical trial results in severe sepsis.
Dhainaut JF; Yan SB; Claessens YE
Crit Care Med; 2004 May; 32(5 Suppl):S194-201. PubMed ID: 15118517
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway.
Joyce DE; Nelson DR; Grinnell BW
Crit Care Med; 2004 May; 32(5 Suppl):S280-6. PubMed ID: 15118531
[TBL] [Abstract][Full Text] [Related]
13. Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis.
Bernard GR
Crit Care Med; 2003 Jan; 31(1 Suppl):S85-93. PubMed ID: 12544981
[TBL] [Abstract][Full Text] [Related]
14. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.
Barton P; Kalil AC; Nadel S; Goldstein B; Okhuysen-Cawley R; Brilli RJ; Takano JS; Martin LD; Quint P; Yeh TS; Dalton HJ; Gessouron MR; Brown KE; Betts H; Levin M; Macias WL; Small DS; Wyss VL; Bates BM; Utterback BG; Giroir BP
Pediatrics; 2004 Jan; 113(1 Pt 1):7-17. PubMed ID: 14702440
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C and sepsis.
O'Brien LA; Gupta A; Grinnell BW
Front Biosci; 2006 Jan; 11():676-98. PubMed ID: 16146761
[TBL] [Abstract][Full Text] [Related]
16. Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.
De Backer D
Drug Saf; 2007; 30(11):995-1010. PubMed ID: 17973539
[TBL] [Abstract][Full Text] [Related]
17. Platelet factor 4 modulation of the thrombomodulin-protein C system.
Slungaard A
Crit Care Med; 2004 May; 32(5 Suppl):S331-5. PubMed ID: 15118540
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke.
Griffin JH; Zlokovic B; Fernández JA
Semin Hematol; 2002 Jul; 39(3):197-205. PubMed ID: 12124682
[TBL] [Abstract][Full Text] [Related]
19. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology.
Vincent JL
Crit Care; 2001; 5(2):S1-5. PubMed ID: 11379985
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C modulates chemokine response and tissue injury in experimental sepsis.
Sharma GR; Gerlitz B; Berg DT; Cramer MS; Jakubowski JA; Galbreath EJ; Heuer JG; Grinnell BW
Adv Exp Med Biol; 2008; 614():83-91. PubMed ID: 18290317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
